Hospitalogy November 12, 2024
Blake Madden

Drug Distributors continue Vertical Integration Strategy as Cencora, Cardinal make Big Bets

Deals among PE-backed physician practice management players and strategic buyers (drug distributors in this case) are heating up.

On November 6, Cencora bought Retina Consultants of America (RCA) for $4.6B (an 85% stake and $500M in incentive payments).

  • RCA serves 300+ retina specialists in 23 states and sees 2 million patient visits annually.
  • Interestingly RCA specializes in clinical trials in research, which Cencora is sure to have an invested (literally) interest in.
  • Through eventually owning both OneOncology and RCA, Cencora will look to build out a more integrated management services organization (an MSO, as our industry so fondly loves its acronym) to house its services subsidiary.
...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: CMS, Govt Agencies, Health System / Hospital, Insurance, Medicare, Mergers & Acquisitions / JV, Pharma, Pharma / Biotech, Physician, Provider, Trends
The next 15 drugs for Medicare price negotiations
Medicare Negotiations Could Fuel, Not Stifle, Innovation
Google DeepMind CEO: AI-Designed Drugs Coming to Clinical Trials in 2025
DOJ Accuses Walgreens of Filling Millions of Illegitimate Prescriptions
DOJ sues Walgreens for allegedly filling millions of illegal prescriptions, including opioids

Share This Article